Shin Poong Pharm.Co.,Ltd. (019170.KS)
KRW 10370.0
(-5.04%)
KRW 10370.0
(-5.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 200.22 Billion | 209.28 Billion | 189.23 Billion | 197.75 Billion | 189.72 Billion | 187.38 Billion |
| Cost of Revenue | 121.6 Billion | 131.31 Billion | 111.84 Billion | 121.22 Billion | 113.53 Billion | 111.5 Billion |
| Gross Profit | 78.61 Billion | 77.97 Billion | 77.38 Billion | 76.52 Billion | 76.18 Billion | 75.88 Billion |
| Operating Expenses | 127.66 Billion | 111.99 Billion | 91.69 Billion | 68.68 Billion | 70.58 Billion | 68.13 Billion |
| Selling, General and Administrative Expenses | 71.57 Billion | 111.99 Billion | 29.95 Billion | 27.4 Billion | 26.09 Billion | 24.13 Billion |
| Research and Development Expenses | 56.01 Billion | 30.38 Billion | 17.33 Billion | 5.62 Billion | 5.96 Billion | 4.86 Billion |
| Other Expenses | - | -30.38 Billion | 44.4 Billion | 35.65 Billion | 38.52 Billion | 39.13 Billion |
| Cost and Expenses | 247.62 Billion | 131.31 Billion | 203.54 Billion | 189.9 Billion | 184.11 Billion | 179.63 Billion |
| Operating Income | -47.39 Billion | -34.01 Billion | -9.04 Billion | 11.34 Billion | 8.42 Billion | 10.68 Billion |
| Interest Expense | 1.71 Billion | 830.99 Million | 202.05 Million | 2.94 Billion | 4.11 Billion | 4.28 Billion |
| Income Tax Expense | 3.83 Billion | 527.29 Million | 2.54 Billion | 3.29 Billion | 1.72 Billion | 2.36 Billion |
| Earnings before Tax | -53.44 Billion | -34.78 Billion | -8.98 Billion | 8.33 Billion | 7.11 Billion | 5.18 Billion |
| Net Income | -57.32 Billion | -35.3 Billion | -11.52 Billion | 5 Billion | 5.32 Billion | 2.8 Billion |
| Earnings Per Share Basic | -1119.00 | -688.79 | -224.84 | 99.40 | 106.53 | 56.00 |
| Earnings Per Share Diluted | -1118.28 | -688.79 | -224.84 | 99.40 | 106.53 | 56.00 |
| Weighted Average Shares Outstanding | 51.22 Million | 51.26 Million | 51.26 Million | 50.32 Million | 49.97 Million | 50.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.26 Million | 51.26 Million | 51.26 Million | 50.32 Million | 49.97 Million | 50.06 Million |
| Gross Margin | 0.39 | 0.37 | 0.41 | 0.39 | 0.40 | 0.40 |
| EBIT Margin | -0.19 | 0.37 | 0.02 | 0.12 | 0.11 | 0.12 |
| Profit Margin | -0.29 | -0.17 | -0.06 | 0.03 | 0.03 | 0.01 |
| EBITDA | -37.06 Billion | -22.22 Billion | 1.27 Billion | 21.04 Billion | 22.86 Billion | 19.11 Billion |
| Earnings Before Tax Margin | -0.24 | -0.16 | -0.05 | 0.06 | 0.04 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 56.02 Billion | 54 Billion | 200.22 Billion | 49.6 Billion | 49.13 Billion | 53.11 Billion |
| Cost of Revenue | 35.98 Billion | 34.51 Billion | 121.6 Billion | 30.5 Billion | 29.52 Billion | 31.21 Billion |
| Gross Profit | 20.04 Billion | 19.48 Billion | 78.61 Billion | 19.09 Billion | 19.6 Billion | 21.9 Billion |
| Operating Expenses | 21.83 Billion | 23.69 Billion | 127.59 Billion | 34.93 Billion | -30.48 Billion | -31.59 Billion |
| Selling, General and Administrative Expenses | 13.7 Billion | 16.33 Billion | - | 16.76 Billion | 30.48 Billion | 31.59 Billion |
| Research and Development Expenses | 8.12 Billion | 7.36 Billion | - | 18.16 Billion | 9.99 Billion | 8.58 Billion |
| Other Expenses | -25 Billion | 35.31 Million | 491.98 Million | 119.67 Million | -60.96 Billion | -63.19 Billion |
| Cost and Expenses | 57.82 Billion | 58.21 Billion | 249.2 Billion | 65.43 Billion | 29.52 Billion | 31.21 Billion |
| Operating Income | -1.79 Billion | -4.2 Billion | -48.97 Billion | -15.83 Billion | -10.87 Billion | -9.69 Billion |
| Interest Expense | 654.59 Million | 659.74 Million | 1.71 Billion | 666.58 Million | 472.44 Million | 471.33 Million |
| Income Tax Expense | -1.24 Billion | -780.4 Million | 3.83 Billion | 9.42 Billion | -2.94 Billion | -921.57 Million |
| Earnings before Tax | -1.27 Billion | -3.35 Billion | -46.92 Billion | -17.21 Billion | -10.96 Billion | -9.9 Billion |
| Net Income | -52.72 Million | -2.59 Billion | -57.32 Billion | -33.24 Billion | -8.05 Billion | -8.99 Billion |
| Earnings Per Share Basic | -1.03 | -50.67 | - | -648.44 | -157.07 | -175.53 |
| Earnings Per Share Diluted | -1.03 | -50.67 | - | -648.44 | -157.07 | -175.53 |
| Weighted Average Shares Outstanding | 51.26 Million | 51.26 Million | 51.26 Million | 51.26 Million | 51.26 Million | 51.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.26 Million | 51.26 Million | 51.26 Million | 51.26 Million | 51.26 Million | 51.26 Million |
| Gross Margin | 0.36 | 0.36 | 0.39 | 0.39 | 0.40 | 0.41 |
| EBIT Margin | 0.02 | -0.01 | - | -0.26 | 0.40 | 0.41 |
| Profit Margin | -0.00 | -0.05 | -0.29 | -0.67 | -0.16 | -0.17 |
| EBITDA | 1 Billion | -645.41 Million | - | -12.73 Billion | 19.6 Billion | 21.9 Billion |
| Earnings Before Tax Margin | -0.03 | -0.08 | -0.24 | -0.32 | -0.22 | -0.18 |
LSRCF
SINGER
MUNJALAU
NIITMTS
GLMD
SHJBF